Found: 34
Select item for more details and to access through your institution.
Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 15, p. 1965, doi. 10.3390/cells12151965
- By:
- Publication type:
- Article
Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell Lines.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 15, p. 2447, doi. 10.3390/cells11152447
- By:
- Publication type:
- Article
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 4, p. 749, doi. 10.3390/cells11040749
- By:
- Publication type:
- Article
Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors.
- Published in:
- Molecules, 2023, v. 28, n. 3, p. 1061, doi. 10.3390/molecules28031061
- By:
- Publication type:
- Article
Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells.
- Published in:
- Molecules, 2022, v. 27, n. 19, p. 6587, doi. 10.3390/molecules27196587
- By:
- Publication type:
- Article
Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue.
- Published in:
- Molecules, 2021, v. 26, n. 10, p. 2843, doi. 10.3390/molecules26102843
- By:
- Publication type:
- Article
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs.
- Published in:
- Molecules, 2019, v. 24, n. 20, p. 3807, doi. 10.3390/molecules24203807
- By:
- Publication type:
- Article
Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity -- A Critical Update.
- Published in:
- Molecules, 2013, v. 18, n. 6, p. 6311, doi. 10.3390/molecules18066311
- By:
- Publication type:
- Article
Carborane‐Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
- Published in:
- ChemMedChem, 2023, v. 18, n. 14, p. 1, doi. 10.1002/cmdc.202300206
- By:
- Publication type:
- Article
Front Cover: Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity (ChemMedChem 5/2023).
- Published in:
- ChemMedChem, 2023, v. 18, n. 5, p. 1, doi. 10.1002/cmdc.202300096
- By:
- Publication type:
- Article
Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
- Published in:
- ChemMedChem, 2023, v. 18, n. 5, p. 1, doi. 10.1002/cmdc.202200583
- By:
- Publication type:
- Article
Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019).
- Published in:
- ChemMedChem, 2019, v. 14, n. 3, p. 290, doi. 10.1002/cmdc.201900048
- By:
- Publication type:
- Article
Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
- Published in:
- ChemMedChem, 2019, v. 14, n. 3, p. 315, doi. 10.1002/cmdc.201800685
- By:
- Publication type:
- Article
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1650, doi. 10.3390/ijms24021650
- By:
- Publication type:
- Article
T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation †.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1198, doi. 10.3390/ijms22031198
- By:
- Publication type:
- Article
1-(4-Fluorobenzoyl)-9 H -carbazole.
- Published in:
- Molbank, 2022, v. 2022, n. 3, p. M1430, doi. 10.3390/M1430
- By:
- Publication type:
- Article
Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents (Adv. Therap. 8/2023).
- Published in:
- Advanced Therapeutics, 2023, v. 6, n. 8, p. 1, doi. 10.1002/adtp.202370022
- By:
- Publication type:
- Article
Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents.
- Published in:
- Advanced Therapeutics, 2023, v. 6, n. 8, p. 1, doi. 10.1002/adtp.202300117
- By:
- Publication type:
- Article
In Vitro Cytostatic Effect on Tumor Cells by Carborane‐Based Dual Cyclooxygenase‐2 and 5‐Lipoxygenase Inhibitors (Adv. Therap. 4/2023).
- Published in:
- Advanced Therapeutics, 2023, v. 6, n. 4, p. 1, doi. 10.1002/adtp.202370011
- By:
- Publication type:
- Article
In Vitro Cytostatic Effect on Tumor Cells by Carborane‐Based Dual Cyclooxygenase‐2 and 5‐Lipoxygenase Inhibitors.
- Published in:
- Advanced Therapeutics, 2023, v. 6, n. 4, p. 1, doi. 10.1002/adtp.202200252
- By:
- Publication type:
- Article
Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59059-3
- By:
- Publication type:
- Article
Synthesis and preliminary radiopharmacological characterisation of an <sup>11</sup>C‐labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 8, p. 448, doi. 10.1002/jlcr.3729
- By:
- Publication type:
- Article
Preclinical evaluation of an <sup>18</sup>F-labeled N<sup>ε</sup>-acryloyllysine piperazide for covalent targeting of transglutaminase 2.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00231-1
- By:
- Publication type:
- Article
2-Carbaborane-3-phenyl-1 H-indoles-Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity.
- Published in:
- ChemMedChem, 2013, v. 8, n. 2, p. 329, doi. 10.1002/cmdc.201200455
- By:
- Publication type:
- Article
Shell engineering in soft alginate‐based capsules for culturing liver spheroids.
- Published in:
- Biotechnology Journal, 2023, v. 18, n. 6, p. 1, doi. 10.1002/biot.202200365
- By:
- Publication type:
- Article
Synthesis and In Vitro Biological Evaluation of p -Carborane-Based Di- tert -butylphenol Analogs.
- Published in:
- Molecules, 2023, v. 28, n. 11, p. 4547, doi. 10.3390/molecules28114547
- By:
- Publication type:
- Article
Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro.
- Published in:
- Clinical Hemorheology & Microcirculation, 2015, v. 61, n. 4, p. 615, doi. 10.3233/CH-141923
- By:
- Publication type:
- Article
Controlled immobilization of His-tagged proteins for protein-ligand interaction experiments using Ni<sup>2+</sup>-NTA layer on glass surfaces.
- Published in:
- Clinical Hemorheology & Microcirculation, 2015, v. 61, n. 3, p. 523, doi. 10.3233/CH-151950
- By:
- Publication type:
- Article
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1204543
- By:
- Publication type:
- Article
Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity.
- Published in:
- Amino Acids, 2017, v. 49, n. 1, p. 183, doi. 10.1007/s00726-016-2349-2
- By:
- Publication type:
- Article
Organotypical vascular model for characterization of radioprotective compounds: Studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors.
- Published in:
- Clinical Hemorheology & Microcirculation, 2014, v. 58, n. 1, p. 281, doi. 10.3233/CH-141902
- By:
- Publication type:
- Article
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2749, doi. 10.3390/pharmaceutics15122749
- By:
- Publication type:
- Article
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 5, p. 428, doi. 10.3390/pharmaceutics12050428
- By:
- Publication type:
- Article
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1155, doi. 10.3390/ph14111155
- By:
- Publication type:
- Article